Top

Pathology & Oncology Research

Published in:

01-12-2003 | Article

Significance of p53, Bcl-2, and HER-2/neu protein expression in Omani Arab females with breast cancer

Authors: Mansour A-Moundhri, V. Nirmala, K. Al-Mawaly, S. Ganguly, I. Burney, A. Rizvi, C. Grant

Published in: Pathology & Oncology Research | Issue 4/2003

Title: Significance of p53, Bcl-2, and HER-2/neu protein expression in Omani Arab females with breast cancer
Authors: Mansour A-Moundhri
V. Nirmala
K. Al-Mawaly
S. Ganguly
I. Burney
A. Rizvi
C. Grant
Publication date: 01-12-2003
Publisher: Springer Netherlands
Published in: Pathology & Oncology Research / Issue 4/2003
Print ISSN: 1219-4956
Electronic ISSN: 1532-2807
DOI: https://doi.org/10.1007/BF02893382

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras

Prof. Fabrice Barlesi

Developed by: Springer Medicine

At a glance: The STEP trials

Springer Medicine

Please log in to get access to this content

Other articles of this Issue 4/2003

Synovial sarcoma: A rare tumor of larynx

HCV and HGV infection in Hodgkin’s disease

Giant cell fibroblastoma in a 3-year-old boy

Renal tumor causing haematuria and sepsis

hMLHl and hMSH2 somatic inactivation mechanisms in sporadic colorectal cancer patients

Pseudohyperplastic prostatic adenocarcinoma in transurethral resections of the prostate

Keynote webinar | Spotlight on antibody–drug conjugates in cancer